MAZE
NASDAQStockMaze Therapeutics, Inc.
$51.84+1.39 (+2.75%)
52-Week Range
$7.57
$51.84
Key Stats
Market Cap
2.5B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
4.47
Volume
518.6K
Avg Volume
463.0K
Performance
1M
+7.16%
3M
+33.39%
6M
+122.95%
YTD
+30.34%
1Y
+358.72%
3Y
+224.98%
5Y
+224.98%
Price Chart
ETF Exposure
MAZE is held by 48 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.22% |
| GURU | Global X - Guru Index ETF | 1.77% |
| SBIO | ALPS Medical Breakthroughs ETF | 1.58% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.97% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.96% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.59% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.44% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.28% |
| IWC | iShares Micro-Cap ETF | 0.23% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.19% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.13% |
| FSML | Franklin Small Cap Enhanced ETF | 0.12% |
| IBB | iShares Biotechnology ETF | 0.12% |
| IWN | iShares Russell 2000 Value ETF | 0.07% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.06% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.06% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.06% |
| IWM | iShares Russell 2000 ETF | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.03% |
| UWM | ProShares - Ultra Russell2000 | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
About MAZE ETF Exposure
Maze Therapeutics, Inc. (MAZE) is held by 48 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.5B, MAZE is a widely held institutional stock. The stock currently trades at $51.84. Investors can gain exposure to MAZE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MAZE, sorted by portfolio weight.